Try our beta test site
3 studies found for:    11519501 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA)
Condition: Hypertension
Intervention: Drug: alagebrium chloride (ALT-711)
2 Completed The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling
Conditions: Hypertension;   Hypertrophy, Left Ventricular
Intervention: Drug: ALT-711
3 Completed The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)
Condition: Hypertension
Intervention: Drug: ALT-711

Study has passed its completion date and status has not been verified in more than two years.